RCC

Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
Asim Amin, Arkadiusz Z Dudek, Theodore F Logan, Raymond S Lance, Jeffrey M Holzbeierlein, Jennifer J Knox, Viraj A Master, Sumanta K Pal, Wilson H Miller, Lawrence I Karsh, Irina Y Tcherepanova, Mark A DeBenedette, W Lee Williams, Douglas C Plessinger, Charles A Nicolette, Robert A Figlin

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 14; DOI: 10.1186/s40425-015-0055-3
A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
Hirokazu Matsushita, Yutaka Enomoto, Haruki Kume, Tohru Nakagawa, Hiroshi Fukuhara, Motofumi Suzuki, Tetsuya Fujimura, Yukio Homma, Kazuhiro Kakimi

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 30; DOI: 10.1186/s40425-014-0030-4

Main menu